Can B-type natriuretic peptide (BNP) be measured in ascitic fluid obtained via paracentesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

BNP Measurement in Ascitic Fluid

Yes, BNP can be measured in ascitic fluid obtained via paracentesis, and it serves as a conditional diagnostic test when cardiac ascites is suspected. 1

When to Order Ascitic Fluid BNP

The most recent guidelines explicitly list BNP or NT-proBNP as a conditional test in the diagnostic paracentesis workup—specifically when cardiac ascites is under consideration. 1 This is not part of the routine initial laboratory panel, which mandates only:

  • Neutrophil (PMN) count 1
  • Total protein concentration 1
  • Ascitic fluid albumin 1
  • Culture (bedside inoculation) 1
  • Serum albumin (same day) for SAAG calculation 1

Clinical Context: Serum BNP Is More Accurate

In practice, serum BNP is far more accurate than ascitic fluid BNP for diagnosing heart failure–related ascites and should be your first-line test. 2 A 2014 prospective study of 218 patients with new-onset ascites demonstrated that serum BNP outperformed both SAAG and ascitic fluid total protein:

  • Serum BNP >364 pg/mL: 98% sensitivity, 99% specificity, positive likelihood ratio 168.1—best to rule in heart failure ascites 2
  • Serum BNP ≤182 pg/mL: negative likelihood ratio 0.0—best to rule out heart failure ascites 2
  • These findings were validated in a separate 60-patient cohort 2

The study concluded that serum BNP can streamline the workup of new-onset ascites and may even obviate the need for diagnostic paracentesis when heart failure is uncertain. 2

Practical Algorithm

  1. Obtain serum BNP first in any patient with new-onset ascites where the etiology is unclear or heart failure is possible. 2
  2. If serum BNP ≤182 pg/mL: heart failure ascites is effectively ruled out; proceed with standard ascitic fluid analysis (SAAG, protein, cell count, culture). 2
  3. If serum BNP >364 pg/mL: heart failure ascites is highly likely; ascitic fluid BNP adds little incremental value. 2
  4. If serum BNP is intermediate (182–364 pg/mL) or unavailable: consider measuring ascitic fluid BNP or NT-proBNP as a conditional test. 1

Important Caveats

  • Obesity blunts BNP levels: In patients with BMI ≥35 kg/m², natriuretic peptide thresholds must be adjusted downward (rule-in threshold ≥220 pg/mL for serum NT-proBNP). 3
  • Atrial fibrillation confounds interpretation: Nearly 98% of patients with atrial fibrillation and dyspnea have heart failure with preserved ejection fraction; BNP provides little incremental discrimination in this population. 3
  • SAAG remains essential: Even when BNP is measured, always calculate SAAG to distinguish portal hypertension (SAAG ≥1.1 g/dL) from peritoneal causes (SAAG <1.1 g/dL). 1 Approximately 5% of patients have mixed etiologies (e.g., cirrhosis plus heart failure). 1

Bottom Line

Ascitic fluid BNP can be measured, but serum BNP is the superior, evidence-based test for diagnosing cardiac ascites. 2 Reserve ascitic fluid BNP for situations where serum testing is unavailable or results are equivocal. 1

Related Questions

What are the diagnostic criteria for heart failure according to the American College of Cardiology (ACC)?
What is the clinical significance of an elevated NT-proBNP (N-terminal pro b-type natriuretic peptide) level in heart failure diagnosis?
What are the proBNP (pro-brain natriuretic peptide) reference ranges?
In chronic pelvic pain syndrome, must a patient constantly feel tense pelvic floor muscles?
What are the evidence‑based lifestyle and pharmacologic recommendations for managing hypertension in adults?
What are the indications for initiating regular (short‑acting) insulin, how should it be started and administered, what dosing adjustment algorithm should be used, and what monitoring and safety considerations are important?
What is the most likely diagnosis and recommended next steps for a 56‑year‑old female with hypertension (atenolol, losartan), diabetes (vildagliptin/metformin), allergy to phenylephrine‑containing products, who presents with a 6‑day history of dry cough worsened at night by oily/fried foods, followed by watery nasal discharge with congestion, then a productive cough with yellow sticky sputum, without fever, dyspnea, or pleuritic chest pain, and associated itching and epiphora with congested non‑erythematous turbinates?
Can you provide a physical therapy initial evaluation template that incorporates the International Classification of Functioning, Disability and Health (ICF) components?
What does toxic vacuolation on a complete blood count differential indicate and how should it be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.